Case Study: Emerging Biopharmaceutical Company achieves compliant, automated global transparency reporting with IQVIA

IQVIA delivered technology and services to comply with varying reporting deadlines and regulatory requirements

Emerging Biopharmaceutical Company, a US‑headquartered firm, faced a growing compliance burden: manual data entry and Excel-based processes to identify and report transfers‑of‑value (TOVs) for US and French transparency laws. Parsing disparate IT systems and paper receipts to link payments to HCPs/HCOs strained data quality and staff time, and French reporting added complexity with language, platform, and documentation challenges for the company’s two Europe‑based employees. To meet these needs the customer partnered with IQVIA and adopted IQVIA Transparency Reporting software (ITR).

IQVIA implemented ITR to aggregate spend from Concur, the company CRM, accounts payable, spreadsheets and manual entries, using a unique customer identifier to consolidate all TOVs and automatically generate regulator‑compliant reports. For France, IQVIA’s French‑speaking compliance consultants managed local requirements, thresholds, formatting and government uploads. IQVIA’s combined technology and service approach has produced successful US and French submissions for over five years, easing data extraction, improving controls and predictability, and delivering process and cost efficiencies.